Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.
New access arrangements under the National Immunisation Program (NIP) to provide free catch-up vaccines for all individuals aged 10 to 19 years, and refugees and humanitarian entrants aged 20 years and over from 1 July 2017.
The shingles vaccine, Zostavax®, has been approved to be placed on the National Immunisation Program (NIP), to be provided free of charge from 1 November 2016 to people aged 70 years. There will also be a 5 year catch-up program for people aged 71 to 79 years.
The Australian Government is extending childhood immunisation arrangements for family assistance payments to increase immunisation rates of children residing in Australia.
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.
Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice to support the introduction of Rotarix® to replace RotaTeq® in specified Australian states (Western Australia, South Australia, Victoria and Queensland) from 1 July 2017.
The Department has developed a template which provides a checklist for immunisation providers to consider before vaccinating a patient with Zostavax (pre-vaccination checklist).